Source of donor stem cells impacts incidence of bleeding and platelet and RBC transfusion requirements during stem cell transplantation (SCT): results of the phase III sprint trial of intercept pathogen inactivated platelets

D Vesole, E Stadtmauer, L.T Goodnough, S Coutre, F Howard, J.-S Lin, M.G Conlan, Frank D. Howard

Research output: Contribution to journalArticlepeer-review

Original languageAmerican English
JournalBiology of Blood and Marrow Transplantation
Volume10
DOIs
StatePublished - Feb 1 2004

Disciplines

  • Endocrinology, Diabetes, and Metabolism
  • Immunology and Infectious Disease
  • Medicine and Health Sciences

Cite this